Ross Cocklin is an accomplished inventor based in Indianapolis, IN (US). He has made significant contributions to the field of yeast metabolism, particularly in the identification and utilization of yeast strains that can metabolize pentose sugars in the presence of D-glucose. With a total of 3 patents, his work has implications for various applications in biotechnology and fermentation processes.

Latest Patents

One of Ross Cocklin's latest patents focuses on materials and methods for identifying and using yeast strains that metabolize pentose sugars in the presence of D-glucose. This patent discloses methods for creating and isolating variants of yeasts that can grow on sugars other than D-glucose, even when exposed to 2-deoxy-glucose and D-glucose, which typically inhibit most yeast strains. The selection media for isolating such variants includes pentose sugars like D-xylose, L-glutamine, and 2-deoxy-glucose. Additionally, mutations in the Grr1 and Red genes in certain strains have been shown to produce variants capable of growing on pentose sugars, including D-xylose, in the presence of 2-deoxy-glucose.

Career Highlights

Throughout his career, Ross Cocklin has worked with notable institutions, including Indiana University. His research has contributed to advancements in the understanding of yeast metabolism and its applications in various industries.

Collaborations

Ross has collaborated with several professionals in his field, including Mark Gerard Goebl and Cary Woods. Their combined expertise has furthered research in yeast strains and their metabolic capabilities.

Conclusion

Ross Cocklin's innovative work in yeast metabolism has led to valuable patents that enhance our understanding of yeast strains and their potential applications. His contributions continue to influence the field of biotechnology and fermentation.